Cooper Companies

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cooper Companies excels in Q1, eyes growth through strategic initiatives

Cooper Companies delivered exceptional Q1 results, surpassing revenue and earnings expectations. With a focus on innovation, operational efficiency, and strategic acquisitions, the company is well-positioned for continued growth despite economic uncertainties and supply chain challenges.

Cooper Companies reports record Q2 revenues amidst industry challenges

Cooper Companies delivered a strong Q2 performance with record revenues and solid earnings per share, driven by CooperVision and CooperSurgical.
While facing industry-wide supply chain challenges, Cooper's strategic strengths in product portfolios and geographic diversification position it well for future growth.
Opportunities lie in leveraging successful product lines, addressing operational challenges, and expanding into international markets for sustained growth.
Overall, Cooper remains optimistic about its future growth prospects in the contact lens and fertility markets, despite facing some challenges.

Cooper Companies reports record revenues and optimistic outlook for growth

Cooper Companies delivered strong financial performance, exceeding revenue expectations and showcasing growth in key segments. The company is strategically positioned for sustained growth, with a focus on leveraging market opportunities and optimizing infrastructure investments. Challenges in managing growth and SKU ranges are being addressed to drive future profitability.

Cooper Companies reports record revenues and projects strong growth ahead

Cooper Companies had a stellar year, marked by record revenues and robust growth in key segments. Despite challenges in capacity and cash flow, the company is poised for continued success with confidence in overcoming obstacles. Opportunities in Myopia management, price trends, and share gains position Cooper Companies for a promising future.

Cooper Companies reports record Q1 revenues, eyes global growth opportunities

Cooper Companies delivered a strong Q1 performance with record revenues and raised full-year guidance. The company's focus on key growth areas like myopia management and daily contact lenses bodes well for future success. Addressing challenges in capacity constraints and market fluctuations will be crucial for sustained growth.

Cooper Companies (COO) reports record revenues and growth opportunities

Cooper Companies (COO) reports strong Q2 earnings with record revenues and increased guidance for fiscal 2024. Challenges include system upgrade impact and competitive uncertainties, but opportunities lie in market growth and strategic investments for future growth.

Cooper Companies (COO) excels in Q3 with record revenues and growth

Cooper Companies (COO) showcased robust financial performance in Q3 2024, driven by record revenues and earnings growth across its key segments.
While facing challenges in certain product lines, strategic investments and market-leading positions position the company well for future growth and profitability.
With a focus on innovation and operational excellence, Cooper Companies is poised to capitalize on opportunities for sustained success and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SAN RAMON, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that CooperSurgical has acquired obp Medical Corporation, a U.S. based medical device company that develops and markets differentiated products including single-use vaginal speculums with integrated LED illumination.

CooperCompanies Acquires obp Medical

SAN RAMON, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release second quarter 2021 financial results on Thursday, June 3, 2021, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

CooperCompanies Announces Release Date for Second Quarter 2021

Big Lots

Emergent BioSolutions

SPAR Group

Worthington Industries

According to the Peter Lynch Growth Screen, a Premium All-in-One Screener template, five stocks with high financial strength, good revenue growth and are trading below the Peter Lynch earnings line as of Tuesday are Big Lots Inc. (NYSE:BIG), The Cooper Companies Inc. (NYSE:COO), Emergent BioSolutions Inc. (NYSE:EBS), SPAR Group Inc. (NASDAQ:SGRP) and Worthington Industries Inc. (NYSE:WOR).

5 Peter Lynch Growth Stocks to Consider for 2nd Quarter

Amgen

Amazon

Dollar General

McCormick

NextEra Energy

Verizon

Zoetis

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

2020 shows that investors need to be prepared for anything. These eight retirement stocks can do precisely that.

8 Retirement Stocks to Buy for Any Market Conditions

Myopia could affect 50% of the world population by 2050, and there could be more demand for contact lenses.

The Cooper Companies: Powered By Secular Tailwinds

Robert S. Weiss named Chairman of the Board and William A. Kozy named Vice Chairman and Lead Director Robert S. Weiss named Chairman of the Board and William A. Kozy named Vice Chairman and Lead Director

CooperCompanies Announces New Board Appointments

Vuzix

Cooper Companies' (COO) unit assigns smart glasses to boost productivity in operations.

Cooper Companies' (COO) Unit Assigns Vuzix M400 Smart Glasses

Cooper Companies (COO) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.

Why Cooper Companies (COO) Stock Might be a Great Pick

ROCHESTER, N.Y., March 18, 2021 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), one of the world's leading manufacturers of soft contact lenses, has successfully deployed Vuzix M400 Smart Glasses equipped with LogistiVIEW's Vision+ augmented reality warehouse software to provide hands-free picking guidance at their 275,000 square foot West Henrietta, New York distribution site, which at any given time stores more than 120,000 different contact lens products.

CooperVision Deploys Vuzix M400 Smart Glasses at its Upstate New York Distribution Center

Investors remain optimistic about Cooper Companies (COO) backed by strong CSI and CVI product portfolios and its continued leadership in the specialty lenses market.

Here's Why You Should Retain Cooper Companies (COO) Now

Biogen

Humana

Universal Health Services

According to the GuruFocus All-in-One Screener, a Premium feature, the following guru-owned health care stocks have grown their book value per share over the past decade through March 11.

4 Health Care Stocks Boosting Book Value

Cooper Companies (COO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Cooper Companies (COO) Surges 4.5%: Is This an Indication of Further Gains?

Cooper Companies' (COO) fiscal first-quarter earnings reflect solid segmental performance.

Cooper Companies (COO) Q1 Earnings & Revenues Top Estimates

The Cooper Companies, Inc. (COO) CEO Albert White on Q1 2021 Results - Earnings Call Transcript

Cooper Cos. (COO) delivered earnings and revenue surprises of 14.44% and 3.10%, respectively, for the quarter ended January 2021.

Cooper Cos. (COO) Beats Q1 Earnings and Revenue Estimates

Shares of Cooper Companies (NYSE:COO) fell 2.6% in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 17.84% year over year to $3.17, which beat the estimate of $2.78.

Cooper Companies: Q1 Earnings Insights

SAN RAMON, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal first quarter ended January 31, 2021.

CooperCompanies Announces First Quarter 2021 Results

Cooper Companies (NYSE:COO) releases its next round of earnings this Thursday, March 04. Get the latest predictions in Benzinga's essential guide to the company's Q1 earnings report.

Cooper Companies's Earnings Outlook

SAN RAMON, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the KeyBanc Life Sciences MedTech Investor Forum on Wednesday, March 24, 2021. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 1:15PM ET.

CooperCompanies to Participate in the KeyBanc Life Sciences MedTech Investor Forum

SAN RAMON, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that CooperSurgical has acquired Safe Obstetric Systems, a privately held manufacturer of the medical device, Fetal Pillow®. This FDA approved product is used to elevate the fetal head during a fully dilated cesarean section making the delivery easier and less traumatic for the mother and baby.

CooperCompanies Acquires Safe Obstetric Systems

SAN RAMON, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021. Daniel McBride, Esq, Executive Vice President, Chief Operating Officer & President of CooperVision, will represent the Company in a virtual session scheduled to begin at 1:10PM ET.

CooperCompanies to Participate in the Oppenheimer Annual Healthcare Conference

LOS ANGELES--(BUSINESS WIRE)---- $COO #COO--Angeles Equity Partners Names Annie Chau Chief Operating and Compliance Officer

Angeles Equity Partners Names Annie Chau Chief Operating and Compliance Officer

SAN RAMON, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced it will release first quarter 2021 financial results on Thursday, March 4, 2021, at 4:15 PM ET.   Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

CooperCompanies Announces Release Date for First Quarter 2021

CHARENTON-LE-PONT, France, and SAN RAMON, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- EssilorLuxottica and CooperCompanies, two of the world's leading vision care companies, have entered into an agreement to create a 50/50 joint venture for the acquisition of SightGlass Vision, a U.S. based life sciences company focused on developing innovative spectacle lenses to reduce the progression of myopia in children.

EssilorLuxottica and CooperCompanies Announce Joint Venture for Acquisition of SightGlass Vision

EssilorLuxottica SA

EssilorLuxottica and CooperCompanies Announce Joint Venture for Acquisition of SightGlass Vision

News for Cooper Companies Stock (COO)